Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingJul 17, 2013Guanabenz 8 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-737-2013Class IIOngoingJul 17, 2013Glutathione 200 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-736-2013Class IIOngoingJul 17, 2013Gentamicin Sulfate 80 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-735-2013Class IIOngoingJul 17, 2013Gentamicin 80 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-734-2013Class IIOngoingJul 17, 2013Gentamicin 300 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-733-2013Class IIOngoingJul 17, 2013Gentamicin 0.3% InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-732-2013Class IIOngoingJul 17, 2013Gaba 50 mg/Mag Sulfate 50 mg/Taurine/Theanine 50 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-731-2013Class IIOngoingJul 17, 2013Furosemide 50 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-730-2013Class IIOngoingJul 17, 2013Fluphenazine 25 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-729-2013Class IIOngoingJul 17, 2013Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-728-2013Class IIOngoingJul 17, 2013Estradiol Cypionate 10 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-727-2013Class IIOngoingJul 17, 2013Enrofloxacin 20 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-726-2013Class IIOngoingJul 17, 2013Doxapram 20 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-725-2013Class IIOngoingJul 17, 2013Disodium EDTA InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-724-2013Class IIOngoingJul 17, 2013Diphenhydramine 50 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-723-2013Class IIOngoingJul 17, 2013Diclazuril 10 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-722-2013Class IIOngoingJul 17, 2013Dextrose 50% SolutionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-721-2013Class IIOngoingJul 17, 2013Dexpanthenol 250 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-720-2013Class IIOngoingJul 17, 2013Dexamethasone Sodium Phosphate 6 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-719-2013Class IIOngoingJul 17, 2013Detomidine w/Xylazine 100 mg/mg InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-718-2013Class IIOngoingJul 17, 2013Detomidine 10 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-717-2013Class IIOngoingJul 17, 2013Deslorelin 15 mg vialLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-716-2013Class IIOngoingJul 17, 2013Cre-O-Pan InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-715-2013Class IIOngoingJul 17, 2013Clenbuterol 0.03mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-714-2013Class IIOngoingJul 17, 2013Chlorpromazine HCL 100 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-713-2013Class IIOngoingJul 17, 2013Ceftiofur GM vial 50 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-712-2013Class IIOngoingJul 17, 2013Cal-Phos 1000 InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-711-2013Class IIOngoingJul 17, 2013Calcium Gluconate 23%Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-710-2013Class IIOngoingJul 17, 2013Caco/Copper 6. 2 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-709-2013Class IIOngoingJul 17, 2013Buprenorphine 0.3 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-708-2013Class IIOngoingJul 17, 2013BNP/Dexamethasone Eye OintmentLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-707-2013Class IIOngoingJul 17, 2013Bi mix, compounded by Olympia PharmacyLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-706-2013Class IIOngoingJul 17, 2013Betamethasone Phosphate/Acetate 6 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-705-2013Class IIOngoingJul 17, 2013Betamethasone Sodium Phosphate 12 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-704-2013Class IIOngoingJul 17, 2013Beta Alanine 100 mg/ml / l-carnosine 100 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-703-2013Class IIOngoingJul 17, 2013Atropine Sulfate 50 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-702-2013Class IIOngoingJul 17, 2013Atipamezole 10 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-701-2013Class IIOngoingJul 17, 2013Aminophylline 2.5% InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-700-2013Class IIOngoingJul 17, 2013Aminocaproic Acid 0.5mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-699-2013Class IIOngoingJul 17, 2013Aminocaproic Acid 250 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-698-2013